...
首页> 外文期刊>Clinical drug investigation >Concomitant Use of Gastroprotective Drugs among Elderly NSAID/COX-2 Selective Inhibitor UsersA Nationwide Register-Based Study
【24h】

Concomitant Use of Gastroprotective Drugs among Elderly NSAID/COX-2 Selective Inhibitor UsersA Nationwide Register-Based Study

机译:老年NSAID / COX-2选择性抑制剂使用者同时使用胃保护药物全国注册研究

获取原文
获取原文并翻译 | 示例

摘要

Background and objectives: NSAIDs and cyclo-oxgenase COX-2-selectiveinhibitors have been associated with gastrointestinal GI complications among the elderly. It is recommended that gastroprotective drugs i.e. misoprostol, proton pump inhibitors or high doses of histamine H2 receptor antagonists be taken concomitantly to prevent NSAID-induced GI complications among older people. However, there are concerns that the rate of concomitant use of gastroprotective drugs in elderly NSAID users is too low. This study aimed to investigate the extent to which elderly users of NSAIDs/COX-2-selective inhibitors are concurrently taking gastroprotective drugs, and to determine the factors associated with concomitant use of gastroprotective drugs and NSAIDs/COX-2-selective inhibitors in a nationwide population of older people.
机译:背景与目的:NSAID和环氧化酶COX-2选择性抑制剂与老年人胃肠道GI并发症相关。建议同时服用胃保护药,即米索前列醇,质子泵抑制剂或高剂量的组胺H2受体拮抗剂,以防止老年人服用NSAID引起的胃肠道并发症。然而,令人担忧的是,老年NSAID使用者同时使用胃保护药物的比率太低。这项研究旨在调查NSAIDs / COX-2选择性抑制剂的老年使用者同时服用胃保护药物的程度,并确定在全国范围内同时使用胃保护药和NSAIDs / COX-2选择性抑制剂的相关因素老年人口。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号